澳門:1名由港來澳人士被列爲輸入性新冠無症狀感染者
澳門特區新型冠狀病毒感染應變協調中心公佈,1名由香港來澳的41歲女性香港居民,2月13日入境澳門,昨日(16日)新冠病毒核酸檢測結果呈弱陽性,判定爲輸入性新冠病毒無症狀感染者。
該人士去年5月和6月共接種2劑科興滅活疫苗,2月13日在香港乘坐晚上6時開出的金巴到澳門,入境時隨即接受鼻咽拭子檢測,結果顯示呈陰性,被安排到麗景灣酒店作醫學觀察,2月15日核酸結果陰性,昨日複查結果呈弱陽性,將轉往路環高頂公共衛生臨牀中心隔離治療。
應變協調中心表示,該人士目前無新冠肺炎症狀,結合其流行病學史、臨牀表現及檢測結果,判定爲輸入性新冠病毒無症狀感染者,不列入澳門新冠病毒肺炎確診病例。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.